Kaffa Fakouhi

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou et al. · Journal of Clinical Oncology · 2019 · 701 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients

Henry Krum, H Nolly, Diane L. Workman et al. · Hypertension · 2002 · 211 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome

George L. Bakris, Mark E. Molitch, Ann C. Hewkin et al. · Diabetes Care · 2006 · 185 citations

Medicine, Pharmacology, Pharmacotherapy +17

Phase 1/2 Study of Venetoclax with Low-Dose Cytarabine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy: 1-Year Outcomes

Andrew H. Wei, Stephen A. Strickland, Gail J. Roboz et al. · Blood · 2017 · 58 citations

Medicine, Oncology, Pharmacology +13

Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia

Andrew H. Wei, Stephen A. Strickland, Gail J. Roboz et al. · Blood · 2016 · 45 citations

Medicine, Hematology, Pharmacology +13